Each film coated tablet contains Tenoxicam BP 20 mg.
Tenoxicam is contraindicated in patients who have shown hypersensitivityto the drug.
Caution should be required in patients have symptoms of gastrointestinaldiseases. If peptic ulceration or gastrointestinal bleeding occurs, Tenoxicamshould be immediately withdrawn. It is necessary to adequately monitor thepatient with increased risk of developing renal failure, impaired renalfunction in diabetics, hepatic cirrhosis and congestive heart failure.
The safety of Tenoxicam during pregnancy and lactation have not beenestablished.
Concurrent treatment with salicylate or other NSAIDs should be avoidedbecause of increased risk of undesirable reactions. Co-administration ofTenoxicam and Methotrexate has been associated with reduced renaltubular secretion of methotrexate. As with NSAIDs in general, Tenoxicamshould not be administered concurrently with potassium sparing diuretics.Tenoxicam might attenuate the antihypertensive effects of a-adrenergicblockers and ACE-inhibitors. It may also enhance the effect of antidiabeticdrug (sulphonylurea group).
Tenorix is well tolerated in the recommended doses. The usual side effectsare mild and transient gastric & abdominal discomfort, dyspepsia,heartburn, nausea, dizziness, headache, itching, erythema, rash, urticaria,increase in BUN or creatinine, edema and palpitations. In isolated cases GIperforation,asthma, angioedema and elevated blood pressure may occur.
There is no experience of acute overdosage with Tenoxicam. Overdoseshould be countered by reducing absorption (eg. gastrolavage and charcoal)and speed up elimination (eg. cholestyramine).
Tenorix tablet: Each box containing 3x10 tablets in blister pack.
Store in a cool and dry place. Protect from light.
